Pyrrolidines

Details for Australian Patent Application No. 2009312427 (hide)

Owner Pfizer Limited

Inventors Dack, Kevin Neil; Mills, James Edward John; Skerratt, Sarah Elizabeth

Agent Spruson & Ferguson

Pub. Number AU-B-2009312427

PCT Pub. Number WO2010/052625

Priority 61/112,869 10.11.08 US

Filing date 30 October 2009

Wipo publication date 14 May 2010

Acceptance publication date 20 October 2011

International Classifications

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

19 May 2011 PCT application entered the National Phase

  PCT publication WO2010/052625 Priority application(s): WO2010/052625

20 October 2011 Application Accepted

  Published as AU-B-2009312427

16 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009312446-Multicast and bidirectional unicast signaling in single root multipoint services using RSVP-TE

2009312355-Oxidized lipid compounds and uses thereof